Add BrightSurf on Google Email

Kidney dysfunction may predict sudden cardiac death in patients with heart failure

A recent study published in ESC Heart Failure found that kidney dysfunction can be used as a criterion to stratify patients requiring implantable defibrillators. The research identified two key independent predictors for the risk of sudden cardiac death: left ventricular ejection fraction and estimated glomerular filtration rate.

SourceFujita Health University·JournalESC Heart Failure·TypeObservational study·DateJul 29, 2024

30-year risk of cardiovascular disease may help inform blood pressure treatment decisions

A new study published in Hypertension journal suggests that both 30-year and 10-year risk predictions should be considered when making high blood pressure treatment decisions. The researchers compared two risk prediction tools and found that long-term, 30-year risk may be more important than short-term, 10-year risk for informing medic...

SourceAmerican Heart Association·JournalHypertension·DateJul 15, 2024

Off-the-shelf wearable trackers provide clinically-useful information for patients with heart disease

A study published in Nature Medicine found that off-the-shelf wearable trackers can monitor the response to two treatments for atrial fibrillation and heart failure. The devices provided clinically useful information similar to in-person hospital assessments, with a neural network helping to analyze missing data.

SourceUniversity of Birmingham·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJul 15, 2024

Researchers at Lewis Katz School of Medicine at Temple University elucidate mechanism behind cardiac fibrosis, opening way for new heart failure treatments

Scientists have identified a critical genetic mechanism driving cardiac fibrosis and found a novel target for its reversal. The discovery sheds light on the role of transforming growth factor-beta (TGFβ) and ATP-citrate lyase (ACLY) in promoting excessive tissue scarring, providing hope for new heart failure treatments.

SourceTemple University Health System·JournalNature Cardiovascular Research·DateJul 10, 2024

Combining popular diabetes drugs offers complementary heart and kidney benefits

Researchers found that combining sodium glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists reduces the risk of major adverse cardiovascular events and chronic kidney disease progression by 11% and 33%, respectively. The study suggests using this combination to further improve outcomes in patients with typ...

SourceGeorge Institute for Global Health·JournalThe Lancet Diabetes & Endocrinology·TypeMeta-analysis·DateJul 8, 2024

Palliative care beneficial to manage symptoms, improve quality of life for people with CVD

A new American Heart Association scientific statement highlights the benefits of palliative care in managing symptoms and improving quality of life for people with cardiovascular disease. Palliative care complements standard cardiovascular care by reducing physical symptoms, emotional distress, and assisting patients in making decision...

SourceAmerican Heart Association·JournalCirculation·DateJul 1, 2024

Standardized protocols help hospitals treat strokes faster, WVU research finds

Researchers found that hospitals that implemented standardized protocols from the American Heart Association and American Stroke Association saw significant reductions in stroke treatment times. The protocols, which include specific limits on time between symptom onset and hospital arrival, helped medical teams respond more quickly to ...

SourceWest Virginia University·JournalJournal of Operations Management·DateJun 24, 2024

Heart failure in space: scientists calculate potential health threats facing future space tourists in microgravity

Researchers used a model of the heart and lung system to simulate how microgravity could affect space tourists with underlying health issues, such as heart conditions. The study found that entry into microgravity increases cardiac output in all individuals, but for heart failure patients, this increase is accompanied by a dangerous ris...

SourceFrontiers·JournalFrontiers in Physiology·TypeComputational simulation/modeling·DateJun 21, 2024

Women who experience depression during pregnancy or after birth have higher risk of cardiovascular disease

Research published in the European Heart Journal found that women diagnosed with perinatal depression are more likely to develop cardiovascular disease. The study included data from around 600,000 women and found a strong link between perinatal depression and risks of high blood pressure, ischemic heart disease, and heart failure.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateJun 18, 2024

Pro-inflammatory diets are associated with higher levels of the heart failure biomarker NT-proBNP, with potential implications for cardiovascular risk, per study of more than 10,000 US adults

A study of over 10,000 US adults found a strong association between pro-inflammatory diets and elevated NT-proBNP levels, indicating potential increased cardiovascular risk. The research suggests that dietary inflammatory index may be an important factor in heart failure biomarker levels.

SourcePLOS·JournalPLOS ONE·DateJun 5, 2024

Presence of carpal tunnel syndrome may indicate a high risk of developing cardiac amyloidosis, according to study from All of Us Research Program

Researchers found a significant association between carpal tunnel syndrome and the risk of developing heart failure and amyloidosis. Individuals with carpal tunnel syndrome were at a 13% higher risk of heart failure and a threefold higher risk of amyloidosis compared to those without the condition.

SourceUniversity of Alabama at Birmingham·JournalMayo Clinic Proceedings·TypeData/statistical analysis·DateJun 3, 2024

Fewer than 1 in 4 patients receive dietary counseling after a heart attack

A study by the University of Michigan Health Frankel Cardiovascular Center found that only 23% of heart attack patients received dietary counseling within 90 days of hospitalization. Nutrition counseling, often provided by registered dietitian nutritionists, may reduce cardiovascular risk for patients.

SourceMichigan Medicine - University of Michigan·JournalJournal of the Academy of Nutrition and Dietetics·TypeObservational study·DateJun 3, 2024

Study finds older adults hospitalized for heart failure had high risk of kidney complications

Researchers found that 6% of patients with heart failure progressed to dialysis within a year, highlighting the need for integrating heart and kidney care. The study emphasizes prioritizing kidney function assessment in all patients with heart failure and promoting systemic changes to manage both conditions simultaneously.

SourceBrigham and Women's Hospital·JournalJAMA Cardiology·TypeObservational study·DateMay 29, 2024

Understanding a broken heart

A new study reveals that heart failure leaves a 'stress memory' in hematopoietic stem cells, which can lead to recurrent heart failure and other health issues. The researchers propose improving TGF-β levels as a new avenue for treating recurrent heart failure.

SourceUniversity of Tokyo·JournalScience Immunology·TypeRandomized controlled/clinical trial·DateMay 24, 2024

Chinese Medical Journal review explores cell-based immunotherapies for sepsis

Researchers review cell-based therapies for comprehensive sepsis management, highlighting the potential of mesenchymal stem cells and innate immune cells like macrophages. The review also emphasizes the need for further studies on optimal dosage, administration routes, and storage methods to maximize efficacy and safety.

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateMay 16, 2024

New drug makes exercise, everyday tasks easier for people with common heart condition

A clinical trial found that aficamten significantly increased maximum oxygen use in patients with obstructive hypertrophic cardiomyopathy. This improvement enables patients to perform everyday tasks more easily, such as walking and household chores. Researchers believe aficamten has promise as a treatment for this condition.

SourceOregon Health & Science University·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMay 13, 2024

Cardiovascular burden of the V142I transthyretin variant

The V142I transthyretin variant is associated with substantial risk for heart failure hospitalization and death in Black individuals, particularly those with reduced ejection fraction. Further investigation into the complex interplay between the variant, ancestry, social determinants of health, and biological factors is warranted.

SourceJAMA Network·JournalJAMA·DateMay 12, 2024

Small pump for kids awaiting heart transplant shows promise in Stanford Medicine-led trial

A new implantable cardiac pump could revolutionize heart transplant care for children, allowing them to wait at home instead of in the hospital. The device performed well in a feasibility trial, with six out of seven children ultimately undergoing transplants and one child's heart recovering on its own.

SourceStanford Medicine·JournalThe Journal of Heart and Lung Transplantation·TypeExperimental study·DateMay 7, 2024

Haiti study suggests early-onset heart failure is prevalent form of heart disease in low-income countries

A Weill Cornell Medicine study found that over 15-fold more Haitians have early-onset heart failure than previously thought, with elevated blood pressure being the leading risk factor. The research suggests a shift in focus to early prevention and treatment of cardiovascular diseases in low-income countries.

SourceWeill Cornell Medicine·JournalThe Lancet Regional Health - Americas·DateApr 29, 2024

Reticulon 3 deficiency ameliorates post-myocardial infarction heart failure by alleviating mitochondrial dysfunction and inflammation

Researchers found that reticulon 3 (RTN3) is downregulated in left ventricular tissue of patients with heart failure after myocardial infarction. RTN3 knockout alleviated cardiac dysfunction after MI, while overexpression decreased systolic function.

SourceSichuan International Medical Exchange and Promotion Association·JournalMedComm·TypeExperimental study·DateApr 18, 2024

Researchers find that accelerated aging biology in the placenta contributes to a rare form of pregnancy-related heart failure

Researchers found that accelerated aging biology in the placenta contributes to peripartum cardiomyopathy (PPCM), a rare form of pregnancy-related heart failure. The study identifies underlying aging-related biology contributing to maternal heart failure and provides evidence from both patients and animal models.

SourceMassachusetts General Hospital·JournalScience Translational Medicine·TypeExperimental study·DateApr 17, 2024

CNIC scientists identify therapeutic targets for the prevention of heart injury linked to cancer treatment

Scientists at CNIC have identified mechanisms by which anthracyclines damage the hearts of cancer patients, leading to cardiac injury. The study suggests that a protein-enriched diet may prevent muscle atrophy caused by anthracycline chemotherapy.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalJACC CardioOncology·TypeExperimental study·DateApr 16, 2024